ICON plc - Ordinary Shares (ICLR)

Elliott Investment Management made several portfolio moves in the fourth quarter, closing multiple options positions and shaking up the activist firm's technology exposure.

When you look at ICON PLC (NASDAQ:ICLR), it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.

Eleven large-cap stocks were the worst performers in the last week. Short positions announced for FTAI, revenue updates for MRNA, and price forecasts changed for GME, SNAP, RKLB, NTRA, LLY, ICLR, BNTX, NVO, and BMRN.

ICON forecasts 2025 revenue at $8.05 billion–$8.65 billion and adjusted EPS of $13.00–$15.00, citing biopharma spending cuts and biotech recovery delays.

For those who appreciate value investing, ICON PLC (NASDAQ:ICLR) is a compelling option with its solid fundamentals.

We are looking for value in the Healthcare Sector because we are still in a strong bull market that has been not only one of the longest on record, but also has seen the S&P 500 get to one of its lofty valuations ever.

Elliott Investment Management was busy in the third quarter. According to a new 13-F filing with the SEC, the activist made several portfolio moves, with multiple new positions focused around travel and lodging.

Ten large-cap stocks: ICON, Genuine Parts, Newmont, Tenet Healthcare, Universal Health, HCA Healthcare, TopBuild, Carlisle, Teradyne, Comfort Systems.

Avantor stock had its Relative Strength (RS) Rating upgraded from 78 to 84 Tuesday amid positive Q2 earnings results.

ICLR stock results show that Icon beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

IQVIA Holdings Inc (NASDAQ:IQV) reported a second adjusted EPS of $2.64, up from $2.43, beating the consensus of $2.57.